ZTS Stock Analysis: Buy, Sell, or Hold?
ZTS - ZOETIS INC.
$76.56
-0.35 (-0.46%)
▼
5d:
+1.32%
30d:
-3.49%
90d:
-35.69%
BUY
HIGH Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 06, 2026
18d
Smart Money Distribution
None View Scanner →
Strength: 5.5/10
Get Alerted When ZTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ZTS trading at deep discount. Market pricing in -11.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ZTS trading at deep discount. Market pricing in -11.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$147.26
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$91.44
16.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZTS is currently trading at $76.56, which is considered fair relative to its 30-day fair value range of $74.20 to $79.42. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.4) compared to its historical average (15.0). Remarkably, the market is currently pricing in an annual earnings decline of 11.6% over the next few years. This pessimistic expectation contrasts with the company's recent 6.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ZTS is in a strong downtrend. The price is approaching resistance at $78.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZTS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $114.76 (+49.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZTS is in a strong downtrend. The price is approaching resistance at $78.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZTS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $114.76 (+49.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$74.20 -
$79.42
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 49.9% below Wall St target ($114.76)
Trading Range Analysis
30-Day Trading Range
$74.20 -
$79.42
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$73.06
Resistance Level
$78.05
Current Trend
Strong Downtrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.36
Wall Street Target
$114.76
(+49.9%)
Revenue Growth (YoY)
2.9%
Earnings Growth (YoY)
6.0%
Profit Margin
28.0%
Valuation Discount vs History
-11.6% cheaper
PE vs Historical
10.4 vs 15.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.6%
(market-implied from PE analysis)
1-Year Target
$68.90
(-10%)
2-Year Target
$62.01
(-19%)
3-Year Target
$55.81
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→15)
$80.82
(+6%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.0, Growth: 7.7%)
$193.89
(+153%)
Base:
(SPY PE: 10.4, Growth: 7.7%)
$95.60
(+25%)
Bear:
(PE: 8.8, Growth: 7.7%)
$81.26
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 12.23 | Current EPS (TTM): $6.29
Bull Case
$99.41
(+30%)
Analyst growth 17.5%, PE expands to 13.5
Base Case
$90.37
(+18%)
Market implied 17.5%, PE stable at 12.2
Bear Case
$52.30
(-32%)
Severe decline -20.0%, PE contracts to 10.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.4 to 15.0
Stabilization Target:
$110.86
(+44.8%)
PE Expansion Potential:
+44.8%
Share & Embed Analysis
Last updated: July 18, 2026 4:50 AM ET
Data refreshes hourly during market hours. Next update: 5:50 AM
Data refreshes hourly during market hours. Next update: 5:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZTS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Gilbert Ray Cisneros, Jr.
SELL
2026-03-13
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 64 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 53 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 53 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced ZTS Option Strategies
Professional options setups generated by AI based on today's ZTS price and gamma walls.
